961.14(3)(d) (d) Codeine methylbromide;
961.14(3)(e) (e) Codeine-N-oxide;
961.14(3)(f) (f) Cyprenorphine;
961.14(3)(g) (g) Desomorphine;
961.14(3)(h) (h) Dihydromorphine;
961.14(3)(hm) (hm) Drotebanol;
961.14(3)(j) (j) Etorphine, except its hydrochloride salts;
961.14(3)(k) (k) Heroin;
961.14(3)(m) (m) Hydromorphinol;
961.14(3)(n) (n) Methyldesorphine;
961.14(3)(p) (p) Methyldihydromorphine;
961.14(3)(q) (q) Morphine methylbromide;
961.14(3)(r) (r) Morphine methylsulfonate;
961.14(3)(s) (s) Morphine-N-oxide;
961.14(3)(t) (t) Myrophine;
961.14(3)(u) (u) Nicocodeine;
961.14(3)(v) (v) Nicomorphine;
961.14(3)(w) (w) Normorphine;
961.14(3)(x) (x) Pholcodine;
961.14(3)(y) (y) Thebacon.
961.14(4) (4)Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
961.14(4)(a) (a) 3,4-methylenedioxyamphetamine, commonly known as “MDA";
961.14(4)(ag) (ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE";
961.14(4)(am) (am) 3,4-methylenedioxymethamphetamine, commonly known as “MDMA";
961.14(4)(ar) (ar) N-hydroxy-3,4-methylenedioxyamphetamine;
961.14(4)(b) (b) 5-methoxy-3,4-methylenedioxyamphetamine;
961.14(4)(bm) (bm) 4-ethyl-2,5-dimethoxyamphetamine, commonly known as “DOET";
961.14(4)(c) (c) 3,4,5-trimethoxyamphetamine;
961.14(4)(cm) (cm) Alpha-ethyltryptamine;
961.14(4)(d) (d) Bufotenine;
961.14(4)(e) (e) Diethyltryptamine;
961.14(4)(f) (f) Dimethyltryptamine;
961.14(4)(g) (g) 4-methyl-2,5-dimethoxyamphetamine, commonly known as “STP";
961.14(4)(h) (h) Ibogaine;
961.14(4)(j) (j) Lysergic acid diethylamide, commonly known as “LSD";
961.14(4)(m) (m) Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;
961.14(4)(mn) (mn) Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);
961.14(4)(n) (n) Phencyclidine, commonly known as “PCP";
961.14(4)(p) (p) N-ethyl-3-piperidyl benzilate;
961.14(4)(q) (q) N-methyl-3-piperidyl benzilate;
961.14(4)(r) (r) Psilocybin;
961.14(4)(s) (s) Psilocin;
961.14(4)(sm) (sm) Salvinorin A;
961.14(4)(t) (t) Tetrahydrocannabinols, commonly known as “THC", in any form including tetrahydrocannabinols contained in marijuana, obtained from marijuana, or chemically synthesized, except that tetrahydrocannabinols do not include cannabidiol in a form without a psychoactive effect that is dispensed or documented as provided in s. 961.38 (1n);
961.14(4)(tb) (tb) Synthetic cannabinoids, including:
961.14(4)(tb)1. 1. Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)1.a. a. 1-pentyl-2-methyl-3-(1-naphthoyl)indole, commonly known as JWH-007;
961.14(4)(tb)1.b. b. 1-propyl-2-methyl-3-(1-naphthoyl)indole, commonly known as JWH-015;
961.14(4)(tb)1.c. c. 1-pentyl-3-(1-naphthoyl)indole, commonly known as JWH-018 or AM-678;
961.14(4)(tb)1.d. d. 1-hexyl-3-(1-naphthoyl)indole, commonly known as JWH-019;
961.14(4)(tb)1.e. e. 1-butyl-3-(1-naphthoyl)indole, commonly known as JWH-073;
961.14(4)(tb)1.f. f. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole, commonly known as JWH-081;
961.14(4)(tb)1.g. g. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole, commonly known as JWH-098;
961.14(4)(tb)1.h. h. 1-pentyl-3-(4-methyl-1-naphthoyl)indole, commonly known as JWH-122;
961.14(4)(tb)1.i. i. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole, commonly known as JWH-164;
961.14(4)(tb)1.j. j. 1-[2-(4-(morpholinyl)ethyl)]-3-(1-naphthoyl)indole, commonly known as JWH-200;
961.14(4)(tb)1.k. k. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole, commonly known as JWH-210;
961.14(4)(tb)1.L. L. 1-pentyl-3-(4-chloro-1-naphthoyl)indole, commonly known as JWH-398;
961.14(4)(tb)1.m. m. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole, commonly known as JWH-412;
961.14(4)(tb)1.n. n. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-naphthoyl)indole, commonly known as AM-1220;
961.14(4)(tb)1.o. o. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole, commonly known as AM-2201;
961.14(4)(tb)1.p. p. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole, commonly known as MAM-2201;
961.14(4)(tb)1.q. q. 1-(5-chloropentyl)-3-(1-naphthoyl)indole, commonly known as AM-2201 (5-chloropentyl);
961.14(4)(tb)1.r. r. 1-(5-bromopentyl)-3-(1-naphthoyl)indole, commonly known as AM-2201 (5-bromopentyl);
961.14(4)(tb)1.s. s. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole, commonly known as AM-2232;
961.14(4)(tb)1.t. t. (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone, commonly known as WIN 55,212-2;
961.14(4)(tb)2. 2. Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)2.a. a. 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole, commonly known as JWH-307;
961.14(4)(tb)2.b. b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole, commonly known as JWH-370;
961.14(4)(tb)2.c. c. 1-pentyl-3-(1-naphthoyl)pyrrole, commonly known as JWH-030;
961.14(4)(tb)2.d. d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole, commonly known as JWH-147;
961.14(4)(tb)3. 3. Any compound structurally derived from 3-naphthylmethylindene by substitution at the 1-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include 1-pentyl-3-(1-naphthylmethyl)indene, commonly known as JWH-176;
961.14(4)(tb)4. 4. Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)4.a. a. 1-pentyl-3-(4-methoxyphenylacetyl)indole, commonly known as JWH-201;
961.14(4)(tb)4.b. b. 1-pentyl-3-(3-methoxyphenylacetyl)indole, commonly known as JWH-302;
961.14(4)(tb)4.c. c. 1-pentyl-3-(2-methoxyphenylacetyl)indole, commonly known as JWH-250;
961.14(4)(tb)4.d. d. 1-pentyl-3-(2-chlorophenylacetyl)indole, commonly known as JWH-203;
961.14(4)(tb)4.e. e. 1-pentyl-3-(3-chlorophenylacetyl)indole, or 3-chloro isomer of JWH-203;
961.14(4)(tb)4.f. f. 1-pentyl-3-(4-chlorophenylacetyl)indole, or 4-chloro isomer of JWH-203;
961.14(4)(tb)4.g. g. 1-pentyl-3-(2-methylphenylacetyl)indole, commonly known as JWH-251;
961.14(4)(tb)4.h. h. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole, commonly known as RCS-8;
961.14(4)(tb)4.i. i. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-methoxyphenylacetyl)indole, commonly known as cannabipiperidiethanone;
961.14(4)(tb)5. 5. Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not substituted in the cyclohexyl ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)5.a. a. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol, commonly known as CP 47,497;
961.14(4)(tb)5.b. b. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol, commonly known as CP 47,497 C8 homologue, or cannabicyclohexanol;
961.14(4)(tb)6. 6. Any compound structurally derived from 3-(benzoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)6.a. a. 1-pentyl-3-(2-iodobenzoyl)indole, commonly known as AM-679;
961.14(4)(tb)6.b. b. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole, commonly known as AM-694;
961.14(4)(tb)6.c. c. 1-pentyl-3-(4-methoxybenzoyl)indole, commonly known as RCS-4;
Loading...
Loading...
This is an archival version of the Wis. Stats. database for 2015. See Are the Statutes on this Website Official?